US equities |
INTC $66.11 ▼-28.19% AMZN $241.37 ▼-0.99% MU $890.83 ▼-4.65% NVDA $206.48 ▼-3.36% GOOGL $282.33 ▼-0.52% SNDK $1,191.36 ▼-10.43% SPCX $138.12 ▼-4.01% AMD $513.71 ▼-9.31%
FinancialContent

Articles published by LadRx Corporation

News headline image
LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Issues 2024 Update to Shareholders
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Announces Reverse Stock Split Effective as of May 17, 2023
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Announces Reverse Stock Split
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Highlights Patent Issued for Its LADR Technology
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Announces Review of Strategic Alternatives and Provides Corporate Updates
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Corporation Issues Corporate Update for 3Q22
From LadRx Corporation
Via Business Wire
Tickers LADX
News headline image
LadRx Corporation Announces OTCQB Ticker Change to LADX
From LadRx Corporation
Via Business Wire
Tickers CYTR